Expression of HPV, steroid receptors (ERα, ERβ, PR-A and PR-B) and inhibin/activin subunits (α, βA and βB) in adenosquamous endometrial carcinoma

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2011-2017

  Gingelmaier, Andrea ^a   Gutsche, Stefanie ^a   Mylonas, Ioannis ^a   Shabani, Naim ^a   Kuhn, Christina ^a   Kunze, Susanne ^a   Jeschke, Udo ^a   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenosquamous carcinoma; Endometrium; HPV; Immunohistochemistry; Inhibin; Steroid receptors

Indexed keywords

ACTIVIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INHIBIN; INHIBIN ALPHA; INHIBIN BETA A; INHIBIN BETA B; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ACTIVINS; ADULT; AGED; ANTIGENS, VIRAL; CARCINOMA, ADENOSQUAMOUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, STEROID; TUMOR MARKERS, BIOLOGICAL;

EID: 34250700920     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Haqqani MT and Fox H: Adenosquamous carcinoma of the endometrium. J Clin Pathol 29: 959-966, 1976.
2. Pekin T, Yildizhan B, Eren F, Pekin O and Yildizhan R: Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium. Eur J Gynaecol Oncol 22: 151-153, 2001.
3. Creasman WT: Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol 24: S1-140-S141-150, 1997.
4. Abeler VM and Kjorstad KE: Endometrial adenocarcinoma with squamous cell differentiation. Cancer 69: 488-495, 1992.
5. Czerwenka K, Lu Y, Heuss F, Manavi M and Kubista E: Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol Oncol 61: 210-214, 1996.
6. O'Leary JJ, Landers RJ, Crowley M, Healy I, O'Donovan M, Healy V, Kealy WF, Hogan J and Doyle CT: Human papillomavirus and mixed epithelial tumors of the endometrium. Hum Pathol 29: 383-389, 1998.
7. Brewster WR, Monk BJ, Burger RA, Bergen S and Wilczynski SP: Does human papilloma virus have a role in cancers of the uterine corpus? Gynecol Oncol 75: 51-54, 1999.
8. Geisinger KR, Homesley HD, Morgan TM, Kute TE and Marshall RB: Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors. Cancer 58: 1518-1525, 1986.
9. Ehrlich CE, Young PC, Stehman FB, Sutton GP and Alford WM: Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158: 796-807, 1988.
10. Carcangiu ML, Chambers JT, Voynick IM, Pirro M and Schwartz PE: Immuno-histochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations. Am J Clin Pathol 94: 247-254, 1990.
11. Chambers JT, Carcangiu ML, Voynick IM and Schwartz PE: Immunohisto-chemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol 94: 255-260, 1990.
12. Kadar N, Malfetano JH and Homesley HD: Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients. Gynecol Oncol 50: 281-286, 1993.
13. Creasman WT: Prognostic significance of hormone receptors in endometrial cancer. Cancer 71: 1467-1470, 1993.
14. Nielsen AL and Nyholm HC: Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (ki-67 paraffin), cathepsin D, and C-erbB-2 protein (p185). Int J Gynecol Pathol 14: 230-234, 1995.
15. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P et al: Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44: 1-34, 1988.
16. Welt CK: Regulation and function of inhibins in the normal menstrual cycle. Seminars in Reproductive Medicine 22: 187-193, 2004.
17. Petraglia F, Florio P, Luisi S, Gallo R, Gadducci A, Vigano P, Di Blasio AM, Genazzani AR and Vale W: Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 83: 1194-1200, 1998.
18. Mylonas I, Winkler L, Jeschke U, Briese V and Friese K: Investigations on isolation, purification and cultivation of human endometrial cells and on the in vitro inhibin expression in glandular epithelial cells. Zentralbl Gynakol 125: 415-423, 2003.
19. Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS and Friese K: Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol 122: 461-471, 2004.
20. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V and Friese K: Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Gynecol Oncol 93: 92-97, 2004.
21. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ and Bradley A: Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319, 1992.
22. Mylonas I, Makovitzky J, Hoeing A, Richter DU, Vogl J, Schulze S, Jeschke U, Briese V and Friese K: Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue. Acta Histochem 108: 1-11, 2006.
23. Worbs S, Shabani N, Mayr D, Gingelmaier A, Makrigiannakis A, Kuhn C, Jeschke U, Kupka MS, Friese K and Mylonas I: Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers. Oncol Rep 17: 97-104, 2007.
24. Mylonas I, Jeschke U, Shabani N, Kuhn C, Balle A, Kriegel S, Kupka MS and Friese K: Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochem 106: 245-252, 2004.
25. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kriegel S, Kupka MS and Friese K: Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res 25: 1679-1686, 2005.
26. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kunze S, Dian D, Friedl C, Kupka MS and Friese K: Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 22: 169-176, 2007.
27. Mylonas I, Shabani N, Vogl J, Makovitzky J, Kunze S, Kuhn C, Schulze S, Friese K and Jeschke U: Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles. Anticancer Res 27(4): 1995-2000, 2007.
28. Mylonas I, Schiessl B, Jeschke U, Vogl J, Makrigiannakis A, Kuhn C, Schulze S, Kainer F and Friese K: Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic and HELLP pregnancies. Endocr Pathol 17: 19-34, 2006.
29. Mylonas I, Schiessl B, Jeschke U, Vogl J, Makrigiannakis A, Kuhn C, Kunze S, Schulze S, Kainer F and Friese K: Expression of inhibin/activin subunits alpha (-alpha), beta A (-beta (A)) and beta B (-beta (B)) in placental tissue of normal and intrauterine growth restricted (IUGR) pregnancies. J Mol Histol 37: 43-52, 2006.
30. Remmele W and Stegner HE: Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8: 138-140, 1987.
31. Mylonas I, Speer R, Makovitzky J, Richter DU, Briese V, Jeschke U and Friese K: Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114: 405-411, 2000.
32. Mylonas I, Jeschke U, Makovitzky J, Winkler L, Richter DU, Friese K and Briese V: Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). Anticancer Res 23: 1119-1125, 2003.
33. Salazar OM, DePapp EW, Bonfiglio TA, Feldstein ML, Rubin P and Rudolph JH: Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis? Cancer 40: 119-130, 1977.
34. Teshima H, Beaudenon S, Koi S, Katase K, Hasumi K, Masubuchi K and Orth G: Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Arch Gynecol Obstet 259: 169-177, 1997.
35. Semczuk A, Stenzel A, Baranowski W, Rozynska K, Cybulski M, Kostuch M, Jakowicki J and Wojcierowski J: Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: lack of correlation with established prognostic factors. Oncol Rep 7: 905-910, 2000.
36. Chambers JT, MacLusky N, Eisenfield A, Kohorn EI, Lawrence R and Schwartz PE: Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer. Gynecol Oncol 31: 65-81, 1988.
37. Pertschuk LP, Masood S, Simone J, Feldman JG, Fruchter RG, Axiotis CA and Greene GL: Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol 63: 28-33, 1996.
38. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC and Quinn MA: The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 72: 388-393, 1988.
39. Mylonas I, Jeschke U, Winkler L, Makovitzky J, Richter DU, Briese V and Friese K: Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and Cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet 268: 142-150, 2003.
40. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M and Nakano R: Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 91: 685-692, 1998.
41. Mylonas I, Makovitzky J, Fernow A, Richter DU, Jeschke U, Briese V, Gerber B and Friese K: Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps. Arch Gynecol Obstet 272: 59-66, 2005.
42. Florio P, Ciarmela P, Reis FM, Toti P, Galleri L, Santopietro R, Tiso E, Tosi P and Petraglia F: Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma. Eur J Endocrinol 152: 277-284, 2005.